The US Food and Drug Administration has approved the first ever prescribed medicine for Obstructive Sleep Apnea. Read on to ...

(Another type, called central sleep apnea, occurs when the brain doesn’t send the proper ... “We hypothesized, and now have ...

It opens the door for broader coverage and access to Zepbound, which is not currently covered by Medicare and many other ...

Though past research has focused on the health benefits of cheese, the new data examined its direct relationship to the ...

Diagnosis involves polysomnography, and treatment options include CPAP ... These are obstructive, central and mixed sleep apnea. Let’s see what each one is about. 1. Obstructive Sleep Apnea ...

Various medical devices are available to help treat sleep apnea. Choosing the right one comes down to the severity of your condition, your personal preferences, and your lifestyle. Sleep apnea is ...

Dec 20 (Reuters) - The U.S. Food and Drug Administration on Friday approved Eli Lilly's (LLY.N), opens new tab weight-loss ...

Washington (AFP) – US regulators on Friday approved the first drug treatment for sleep apnea, permitting the use of a weight-loss medication for the condition that affects millions of Americans.

Central sleep apnea (CSA ... It’s important to treat sleep apnea in pregnancy early on to prevent other health conditions later for the mother and baby.”This article originally appeared ...

“A 10-year-old with uncontrolled central sleep apnea is about 200 ... and added that treatment of sleep apnea may improve epileptic seizures. The findings were presented on December 7 at the ...

The FDA on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity.

“Today’s approval marks the first drug treatment option for certain patients with obstructive sleep apnea,” said Sally Seymour, M.D., director of the Division of Pulmonology, Allergy, and Critical ...